INC Research has selected TransPerfect’s Trial Interactive as its global electronic Trial Master File (eTMF) solution. Trial Interactive is a web-based platform designed to reduce redundancies of paper-based TMF management.
The technology allows INC Research to deliver realtime access to global project documentation, helping to eliminate much of the travel and shipping associated with TMF reviews and reconciliation, and provides a real-time metrics dashboard to enhance communications with customers and stakeholders. Trial Interactive’s interface is available in more than 20 languages. INC Research will deploy the solution in the local language of the end user, enhancing efficiencies for global study teams, sponsors, and investigative site personnel involved in multinational clinical trials.
“We chose Trial Interactive as our eTMF solution because it offers the greatest compatibility with current and potential customers,” said Todd Esporas, executive director of Clinical Development Services at INC Research. “The system creates efficiencies across our organization and further demonstrates our position as a leading partner to the biopharmaceutical industry. By embracing the latest, most sophisticated technology to accelerate drug development, we are able to deliver clinical trials on behalf of our customers more efficiently.”
Michael Smyth, general manager of TransPerfect’s Life Science Solutions division, said, “We’re very proud that INC Research has chosen Trial Interactive as its eTMF solution. INC’s global reach and commitment to utilizing technology should only serve to benefit their study sponsors as they seek to become more efficient in conducting global clinical trials.”